Puhr M - Search Results

1

Inflammation, Microbiota, and Prostate Cancer.

Puhr M, De Marzo A, Isaacs W, Lucia MS, Sfanos K, Yegnasubramanian S, Culig Z. Puhr M, et al. Eur Urol Focus. 2016 Oct;2(4):374-382. doi: 10.1016/j.euf.2016.08.010. Epub 2016 Aug 28. Eur Urol Focus. 2016. PMID: 28723469 Review.

2

Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer.

Bellezza I, Neuwirt H, Nemes C, Cavarretta IT, Puhr M, Steiner H, Minelli A, Bartsch G, Offner F, Hobisch A, Doppler W, Culig Z. Bellezza I, et al. Among authors: puhr m. Am J Pathol. 2006 Dec;169(6):2199-208. doi: 10.2353/ajpath.2006.060171. Am J Pathol. 2006. PMID: 17148681 Free PMC article.

3

Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion.

Neuwirt H, Puhr M, Cavarretta IT, Mitterberger M, Hobisch A, Culig Z. Neuwirt H, et al. Among authors: puhr m. Endocr Relat Cancer. 2007 Dec;14(4):1007-19. doi: 10.1677/ERC-07-0172. Endocr Relat Cancer. 2007. PMID: 18045952

4

Oligomeric proanthocyanidin complexes (OPC) exert anti-proliferative and pro-apoptotic effects on prostate cancer cells.

Neuwirt H, Arias MC, Puhr M, Hobisch A, Culig Z. Neuwirt H, et al. Among authors: puhr m. Prostate. 2008 Nov 1;68(15):1647-54. doi: 10.1002/pros.20829. Prostate. 2008. PMID: 18663730

5

Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.

Neuwirt H, Puhr M, Santer FR, Susani M, Doppler W, Marcias G, Rauch V, Brugger M, Hobisch A, Kenner L, Culig Z. Neuwirt H, et al. Among authors: puhr m. Am J Pathol. 2009 May;174(5):1921-30. doi: 10.2353/ajpath.2009.080751. Epub 2009 Mar 26. Am J Pathol. 2009. PMID: 19342366 Free PMC article.

6

[Androgens stimulate the expression of SOCS-3 and inhibits their effect on proliferation and secretion].

Neuwirt H, Puhr M, Cavarretta IT, Mitterberger M, Hobisch A, Culig Z. Neuwirt H, et al. Among authors: puhr m. Aktuelle Urol. 2009 Aug;40(4):231-4. doi: 10.1055/s-0028-1098887. Epub 2009 Jul 24. Aktuelle Urol. 2009. PMID: 19634073 German.

7

Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways.

Puhr M, Santer FR, Neuwirt H, Susani M, Nemeth JA, Hobisch A, Kenner L, Culig Z. Puhr M, et al. Cancer Res. 2009 Sep 15;69(18):7375-84. doi: 10.1158/0008-5472.CAN-09-0806. Epub 2009 Sep 8. Cancer Res. 2009. PMID: 19738059

8

SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling.

Puhr M, Santer FR, Neuwirt H, Marcias G, Hobisch A, Culig Z. Puhr M, et al. Endocr Relat Cancer. 2010 May 18;17(2):525-38. doi: 10.1677/ERC-10-0007. Print 2010 Jun. Endocr Relat Cancer. 2010. PMID: 20335309

9

Interleukin-6: a multifunctional targetable cytokine in human prostate cancer.

Culig Z, Puhr M. Culig Z, et al. Among authors: puhr m. Mol Cell Endocrinol. 2012 Sep 5;360(1-2):52-8. doi: 10.1016/j.mce.2011.05.033. Epub 2011 Jun 1. Mol Cell Endocrinol. 2012. PMID: 21664423 Free PMC article. Review.

10

PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21.

Hoefer J, Schäfer G, Klocker H, Erb HH, Mills IG, Hengst L, Puhr M, Culig Z. Hoefer J, et al. Among authors: puhr m. Am J Pathol. 2012 May;180(5):2097-107. doi: 10.1016/j.ajpath.2012.01.026. Epub 2012 Mar 23. Am J Pathol. 2012. PMID: 22449952 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page